- $619.11m
- $720.06m
- $915.45m
Brief: Tilray Brands Q4 Revenue USD 281.714 Million
Brief: Tilray Medical Announces Commercial Launch Of Medical Cannabis In Panama
Focus: Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
Cannabis shares retreat after initial rally on narrow scope of US rescheduling (updated)
Explainer: How US marijuana reclassification could help cannabis companies
Pot firms rally after US reclassifies marijuana as less dangerous drug
Explainer: How US marijuana reclassification could help cannabis companies
Pot stocks rise as US reclassifies state-licensed medical marijuana as a less-dangerous drug
DOJ reclassifies certain marijuana products as a less-dangerous drug (updated)
DOJ reclassifies FDA-approved, state-licensed marijuana as a less-dangerous drug
Explainer: How US marijuana reclassification could help cannabis companies
Pot stocks rise as report says US set to reclassify marijuana
US set to reclassify marijuana as early as Wednesday, Axios reports (updated)
NASDAQ RESUMED AT 12:01 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:49 AM
Brief: Tilray Medical Announces Major Expansion Of Medical Cannabis Portfolio In Australia
Brief: Breckenridge Distillery Expands Its Colorado Presence With Cheba Hut Partnership
Brief: Tilray Brands Inc - Enters Agreement To Buy Brewdog's Key U.S. Assets
Brief: Tilray Brands Enters Agreement To Acquire Brewdog’S Key U.S. Assets, Expanding Its U.S. Craft Beer Platform